Literature DB >> 21515078

Reduction of cold ischemia-reperfusion injury by graft-expressing clusterin in heart transplantation.

Shuyuan Li1, Qiunong Guan, Zhishui Chen, Martin E Gleave, Christopher Y C Nguan, Caigan Du.   

Abstract

BACKGROUND: Cold ischemia-reperfusion injury (IRI) is a major factor for early graft dysfunction and is associated with rejection episodes in heart transplantation. Clusterin (CLU) is a cytoprotective protein with chaperone activity. This study was designed to examine the impact of donor-expressing CLU on cold IRI.
METHODS: Donor hearts from wild-type C57BL/6J (H-2(b); B6 WT) vs CLU knockout C57BL/6J (H-2(b); B6 KO) mice were stored at 4°C for 8 hours, followed by heterotopic transplantation to B6 WT mice. The functional recovery of heart grafts was determined by scoring palpation, and tissue injury was determined by release of creatine kinase (CK) and lactate dehydrase (LDH) and also by histology.
RESULTS: Heart cells constitutively expressed CLU, and mature CLU protein was localized mostly in the endothelium as well as on the cell surface of cardiac myocytes. As compared with CLU-deficient hearts, WT hearts were more resistant to cold injury during cold preservation, and had a better functional recovery after prolonged cold preservation and transplantation. The improved graft function of CLU-expressing grafts correlated significantly with reduced neutrophil infiltration and cardiac injury, including myocytic apoptosis and necrosis. Furthermore, in vitro examination showed that ectopic expression of CLU in cultured myocytes increased cell membrane stability after exposure to cold temperature and prevented cell death.
CONCLUSIONS: CLU expression renders donor hearts resistance to cold IRI in transplantation, suggesting that upregulation of CLU expression in donor hearts may have potential for protecting heart grafts from cold IRI.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515078     DOI: 10.1016/j.healun.2011.03.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  9 in total

Review 1.  Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes.

Authors:  Rodrigo Martins Pereira; Rania A Mekary; Kellen Cristina da Cruz Rodrigues; Chadi Pellegrini Anaruma; Eduardo Rochete Ropelle; Adelino Sanchez Ramos da Silva; Dennys Esper Cintra; José Rodrigo Pauli; Leandro Pereira de Moura
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 2.  Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics.

Authors:  Tomohisa Matsunaga; Maximilian J Roesel; Andreas Schroeter; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

Review 3.  Dysfunctional HDL and atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Nat Rev Cardiol       Date:  2015-09-01       Impact factor: 32.419

4.  Hyperbranched polyglycerol as a colloid in cold organ preservation solutions.

Authors:  Sihai Gao; Qiunong Guan; Irina Chafeeva; Donald E Brooks; Christopher Y C Nguan; Jayachandran N Kizhakkedathu; Caigan Du
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

5.  Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival.

Authors:  Fan Zhang; Masafumi Kumano; Eliana Beraldi; Ladan Fazli; Caigan Du; Susan Moore; Poul Sorensen; Amina Zoubeidi; Martin E Gleave
Journal:  Nat Commun       Date:  2014-12-12       Impact factor: 14.919

6.  Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy.

Authors:  Joanna Iłżecka; Marek Iłżecki; Aneta Grabarska; Shawn Dave; Marcin Feldo; Tomasz Zubilewicz
Journal:  Ups J Med Sci       Date:  2019-08-28       Impact factor: 2.384

7.  miR-21 is upregulated, promoting fibrosis and blocking G2/M in irradiated rat cardiac fibroblasts.

Authors:  Huan Guo; Xinke Zhao; Haixiang Su; Chengxu Ma; Kai Liu; Shanshan Kong; Kedan Liu; Haining Li; Juan Chang; Tao Wang; Hongyun Guo; Huiping Wei; Zhaoyuan Fu; Xinfang Lv; Yingdong Li
Journal:  PeerJ       Date:  2020-12-10       Impact factor: 2.984

8.  Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation.

Authors:  Enshi Wang; Yu Nie; Qian Zhao; Wei Wang; Jie Huang; Zhongkai Liao; Hao Zhang; Shengshou Hu; Zhe Zheng
Journal:  J Cardiothorac Surg       Date:  2013-07-01       Impact factor: 1.637

9.  The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse.

Authors:  Aiping Zhang; Kitipong Uaesoontrachoon; Conner Shaughnessy; Jharna R Das; Sree Rayavarapu; Kristy J Brown; Patricio E Ray; Kanneboyina Nagaraju; John N van den Anker; Eric P Hoffman; Yetrib Hathout
Journal:  Toxicol Rep       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.